Ascorbic Acid Tablets IP 300 mg Exporter in India – Healthy Inc

Ascorbic Acid Tablets IP 300 mg | Exporter
Product image for Ascorbic Acid Tablets IP 300 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Ascorbic Acid |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30045035 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Vitamin and Mineral Supplements |
| Subcategory | Vitamin and Mineral Supplements |
| Active Ingredient | Ascorbic Acid |
| Strength | 300 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Vitamin and Mineral Supplements |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Ascorbic Acid Tablets IP 300 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Prevention and treatment of clinical vitamin and mineral deficiency states. 2. Nutritional supplementation during convalescence, increased physiological demand, pregnancy, and geriatric care. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Ascorbic Acid Tablets IP 300 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Ascorbic Acid Tablets IP 300 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally once daily with meals, or as recommended by the healthcare provider. Swallow whole with water; do not exceed the recommended dietary intake. | ||||||||||||||||||||||||
| Side Effects | Common: Mild gastrointestinal fullness, transient dark stools (with iron), mild nausea. Uncommon: Diarrhea, mild skin flushing, headache. Rare: Allergic hypersensitivity reactions, hypervitaminosis from excessive chronic intake. | ||||||||||||||||||||||||
| Warnings and Precautions | Recommended Allowances: Do not consume in doses exceeding upper tolerable limits without clinical oversight. Renal Compromise: Exercise caution with fat-soluble vitamins or mineral supplements in severe renal impairment. Keep safely out of reach of children. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to any vitamin or active mineral ingredient in the tablet. 2. Preexisting hypervitaminosis or hypercalcemia. 3. Severe renal stone disease (for high-dose calcium/ascorbic acid combinations). | ||||||||||||||||||||||||
| Drug Interactions | 1. Tetracyclines & Fluoroquinolones: Chelation with divalent/trivalent minerals reduces antibiotic absorption; separate by 2 hours. 2. Antiepileptics (Phenytoin): Folate co-administration may alter serum anticonvulsant levels. 3. Levodopa: High doses of pyridoxine may diminish levodopa therapeutic antiparkinsonian response. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Ascorbic Acid Tablets IP 300 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Ascorbic Acid Tablets IP 300 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Ascorbic Acid Tablets IP 300 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Ascorbic Acid Tablets IP 300 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Ascorbic Acid Tablets IP 300 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Ascorbic Acid Tablets BP 500 mg ExporterView product →
✚
Ascorbic Acid Tablets BP 500 mg ManufacturerView product →
✚
Ascorbic Acid Tablets BP 500 mg SupplierView product →
✚
Ascorbic Acid Tablets IP 100 mg ExporterView product →
✚
Ascorbic Acid Tablets IP 100 mg ManufacturerView product →
✚
Ascorbic Acid Tablets IP 100 mg SupplierView product →
✚
Ascorbic Acid Tablets IP 300 mg ManufacturerView product →
✚
Ascorbic Acid Tablets IP 300 mg SupplierView product →
✚
Calcium Gluconate Tablets IP 500 mg ExporterView product →
✚
Calcium Gluconate Tablets IP 500 mg ManufacturerView product →
✚
Calcium Gluconate Tablets IP 500 mg SupplierView product →
✚
Cholecalciferol Granules Tablets ExporterView product →
